Perth participant in the COVID-19 vaccine trial in humans reveals why she wanted to become a guinea pig
Why I became a ‘guinea pig’ of a virus: woman reveals personal reason for spending years on vaccine research – as scientists warn we may need several injections to ward off COVID-19
- Linear clinical trial with COVID-19 trial with a Chinese pharmaceutical product
- Rachelle Kalic said that losing her father to Uber motivated her to participate in a human trial
- Damian Purcell of the Doherty Institute said more than one vaccine is needed
A woman who took part in a coronavirus experiment has revealed that her father lost her job as an Uber driver and motivated her to participate in a groundbreaking human vaccine trial worldwide.
Rachelle Kalic is undergoing injections as part of a Perth-based experiment conducted by Linear Clinical Research with the Chinese pharmaceutical giant Clover Biopharmaceuticals.
For her problems, she gets $ 2,000 for two years and has to refrain from excessive drinking and even strenuous exercise for certain times.
Scroll down for video
Rachelle Kalic is undergoing injections as part of a Perth-based trial of Linear Clinical Research conducted with the Chinese pharmaceutical giant Clover Biopharmaceuticals. She explained that her father lost her job because an Uber driver motivated her
Ms. Kalic said she was driven to participate in one of the world’s first human trials with a coronavirus vaccine.
“It is personal. My dad is an Uber driver, so he saw that his source of income was drying up, “she told the ABC program at 7:30 AM.
So he’s currently on JobKeeper. Mom is a little worried, she thinks it is necessary, she doesn’t understand why I should do it.
“It’s not just someone with a rusty needle in the back of a shed who injects live coronavirus. That’s not the point.’
Professor Damian Purcell, head of molecular virology at the Doherty Institute, said that COVID-19 was so complicated that different vaccines may be needed to fight potential mutations.
“It’s likely that we need more than one vaccine and as much as we can develop is probably the right path at this point,” he told the ABC.
The Linear Clinical Research study is one of 17 COVID-19 clinical evaluation studies worldwide.
Clover Biopharmaceuticals began work on their vaccine candidate in early January, before confirming the first case of COVID-19 in Australia.
The World Health Organization lists 132 pre-clinical evaluations.
The Linear Clinical Research study is one of 17 COVID-19 clinical evaluation studies worldwide. Depicted is a participant helping researchers to develop a new drug
Perth-based Linear Clinical Research is experimenting with a possible COVID-19 vaccine with the Chinese pharmaceutical giant Clover Biopharmaceuticals